RXRX
4.03-0.21 -4.95%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- RXRX
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $2.41B
- Employees
- 600
- Currency
- USD
- Website
- https://www.recursion.com
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2…
Latest coverage
- 1 Big Winner and 1 Loser From the Upcoming Anthropic IPO
October 31, 2026